Silybin and the liver: From basic research to clinical practice

doi:10.3748/wjg.v17.i18.2288

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16094)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-9) series.

Item

Count

PDF

1137

HTML

14786

Tables (1-9)

171

Sum=16094

May 14, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (252)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 14, 2011; 17(18): 2288-2301
Published online May 14, 2011. doi: 10.3748/wjg.v17.i18.2288

Table 2 Pharmacokinetics of silybin after administration to 12 healthy volunteers as silymarin or silybin-phosphatidylcholine-vitamine E complex (RA)[43]

Product	Cmax (ng/mL)	Tmax(h)	AUC (ng/mL per hour)
RA granules (47 mg silybin)	213 ± 166	0.5	246 ± 114
RA capsules (47 mg silybin)	117 ± 93	1.0	161 ± 85
Silymarin gran (58 mg silybin)	18 ± 17	0.5	25 ± 18
Silymarin caps (80 mg silybin)	5 ± 7	1.0	11 ± 5

Citation: Loguercio C, Festi D. Silybin and the liver: From basic research to clinical practice. World J Gastroenterol 2011; 17(18): 2288-2301
URL: https://www.wjgnet.com/1007-9327/full/v17/i18/2288.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i18.2288